SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-192161
Filing Date
2018-06-14
Accepted
2018-06-14 08:02:05
Documents
2
Period of Report
2018-06-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d405429d8k.htm 8-K 16836
2 EX-10.1 d405429dex101.htm EX-10.1 25680
  Complete submission text file 0001193125-18-192161.txt   43924
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 18898166
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services